{
    "title": "105_hr1398",
    "content": "The \"Parkinson's Research Act of 1997\" aims to expand federal investment in Parkinson's disease research and improve coordination among National Institutes of Health research institutes. It also seeks to enhance care and assistance for individuals with Parkinson's and their family caregivers. The Director of NIH will establish a program for Parkinson's disease research and training, coordinating with national research institutes and holding research planning conferences every two years. The Director of NIH will award Core Center Grants for innovative multidisciplinary research and training on Parkinson's disease, designating up to 10 centers as Morris K. Udall Centers for Research on Parkinson's Disease. The Director of NIH will award Core Center Grants for research on Parkinson's disease, designating centers as Morris K. Udall Centers for Research on Parkinson's Disease. These centers must conduct basic and clinical research and may also offer training programs for scientists and health professionals. The Morris K. Udall Centers for Research on Parkinson's Disease may conduct training programs for scientists and health professionals, provide information to health professionals and the public, and establish a nationwide data system for Parkinson's patients. The Morris K. Udall Centers for Research on Parkinson's Disease aim to establish a nationwide data system, a Parkinson's Disease Information Clearinghouse, and a national education program to enhance knowledge and understanding of Parkinson's disease. The Morris K. Udall Centers for Research on Parkinson's Disease focus on fostering a national emphasis on Parkinson's care. The program allows centers to provide stipends for training programs and support for up to five years, extendable upon review. The Director of NIH will establish a grant program to support Parkinson's disease researchers with a proven record of excellence and innovation. Grants will be available for up to 5 years, with an authorization of $100,000,000 for fiscal year 1998 and additional funding for subsequent years. Authorization of $100,000,000 for fiscal year 1998 and additional funding for subsequent years is provided for Parkinson's disease research. Funds cannot be used for research involving human fetal tissue from induced abortions, except for tissue from spontaneous abortions or ectopic pregnancies."
}